title: Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality.
abstract: The prostaglandin G/H synthase enzymes, commonly termed COX-1 and COX-2, differ markedly in their responses to regulatory stimuli and their tissue expression patterns. COX-1 is the dominant source of "housekeeping" prostaglandins, whereas COX-2 synthesizes prostaglandins of relevance to pain, inflammation, and mitogenesis. Despite these distinctions, the two enzymes are remarkably conserved, and their subcellular distributions overlap considerably. To address the functional interchangeability of the two isozymes, mice in which COX-1 is expressed under COX-2 regulatory elements were created by a gene targeting "knock-in" strategy. In macrophages from these mice, COX-1 was shown to be lipopolysaccharide-inducible in a manner analogous to COX-2 in wild-type macrophages. However, COX-1 failed to substitute effectively for COX-2 in lipopolysaccharide-induced prostaglandin E2 synthesis at low concentrations of substrate and in the metabolism of the endocannabinoid 2-arachidonylglycerol. The marked depression of the major urinary metabolite of prostacyclin in COX-2 null mice was only partially rescued by COX-1 knock-in, whereas the main urinary metabolite of prostaglandin E2 was rescued totally. Replacement with COX-1 partially rescued the impact of COX-2 deletion on reproductive function. The renal pathology consequent to COX-2 deletion was delayed but not prevented, whereas the corresponding peritonitis was unaltered. Insertion of COX-1 under the regulatory sequences that drive COX-2 expression indicated that COX-1 can substitute for some COX-2 actions and rescue only some of the consequences of gene disruption. Manipulation of COX-2 also revealed a preference for coupling with distinct downstream prostaglandin synthases in vivo. These mice will provide a valuable reagent with which to elucidate the distinct roles of the COX enzymes in mammalian biology.
authors.affiliation: Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
authors.forename: Ying
authors.initials: Y
authors.lastname: Yu
authors.forename: Jinjin
authors.initials: J
authors.lastname: Fan
authors.forename: Yiqun
authors.initials: Y
authors.lastname: Hui
authors.forename: Carol A
authors.initials: CA
authors.lastname: Rouzer
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Marnett
authors.forename: Andres J
authors.initials: AJ
authors.lastname: Klein-Szanto
authors.forename: Garret A
authors.initials: GA
authors.lastname: FitzGerald
authors.forename: Colin D
authors.initials: CD
authors.lastname: Funk
mesh_terms: D020413:3' Untranslated Regions / Q000235:genetics; D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism; D051545:Cyclooxygenase 1 / Q000235:genetics* / Q000378:metabolism*; D051546:Cyclooxygenase 2 / Q000235:genetics* / Q000378:metabolism*; D015232:Dinoprostone / Q000378:metabolism; D063388:Endocannabinoids; D015971:Gene Expression Regulation, Enzymologic; D005989:Glycerides / Q000378:metabolism; D007668:Kidney / Q000201:enzymology / Q000473:pathology; D008264:Macrophages / Q000502:physiology; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D023421:Models, Animal; D010538:Peritonitis / Q000378:metabolism / Q000503:physiopathology; D014158:Transcription, Genetic; D014551:Urinary Tract / Q000201:enzymology
chemical_list: D020413:3' Untranslated Regions; D001095:Arachidonic Acids; D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D005989:Glycerides; D008565:Membrane Proteins; C094503:glyceryl 2-arachidonate; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; C496512:Ptgs1 protein, mouse; D015232:Dinoprostone